Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult With Class V Carious

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04716517
Collaborator
(none)
28
2
13

Study Details

Study Description

Brief Summary

Cention N will have the same clinical performance as resin-modified glass ionomer in cervical carious lesions. Evaluation of restorations will be done at baseline, six months, and one year according (USPHS) criteria.

Condition or Disease Intervention/Treatment Phase
  • Other: Alkasite bioactive restorative material.
  • Other: Resin Modified Glass Ionomer
N/A

Detailed Description

In this study, Class V carious lesions were restored using two different restorative materials either resin modified glass ionomer or Cention N restorative materials. This study will be held in the restorative clinic at Future University in Egypt. Patients will be assessed for medical and dental histories first. Then an examination of the patients will be done using visual inspection by using a dental mirror and probe. Eligible patients according to inclusion and exclusion criteria will be informed about all procedures with follow up time if they accept, 12 their signature on written informed consents will be obtained. Eligible participants will be randomly divided into two groups according to the type of restoration they will be received. The first group (A) will be received resin modified glass ionomer restorative material and the second group (B) will be received Cention N restorative materials. Each restoration will be evaluated for clinical parameters after finishing and polishing at baseline and regular recalls of 6 months and one year.

The restorations will be clinically examined according to modified USPHS criteria in terms of marginal adaptation, anatomic form, color match, marginal discoloration, secondary caries, postoperative sensitivity and retention. The information that will be obtained will be collected and statistically analyzed

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult Patients With Class V Carious Lesions Over One Year Period: Randomized Clinical Trial
Anticipated Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cention N

Intervention Alkasite Restoration will be used to restore cervical carious in adult patients.

Other: Alkasite bioactive restorative material.
Alkasite restorative is a category of filling material, like compomer, and is essentially a subgroup of the composite resin. Cention N is a urethane dimethacrylate (UDMA)-based, self-curing powder/liquid restorative with optional additional light curing. The liquid comprises of dimethacrylates and initiators, while the powder contains various glass fillers, initiators, and pigments. It is radio opaque and contains alkaline glass fillers capable of releasing fluoride, calcium, and hydroxide ions. Due to the sole use of cross-linking methacrylate monomers in combination with a stable, efficient self-cure initiator, Cention N displays a high polymer network density and degree of polymerization over the complete depth of the restoration.
Other Names:
  • (Cention N).
  • Active Comparator: Resin Modified Glass Ionomer

    Comparator Resin-modified glass ionomer material will be used to restore cervical carious in adult patients.

    Other: Resin Modified Glass Ionomer
    The resin-modified glass ionomer materials are hybrid materials of traditional glass ionomer cement with a small addition of light-curing resin, and hence exhibit properties intermediate to the two, with some characteristics superior to conventional glass ionomer materials

    Outcome Measures

    Primary Outcome Measures

    1. (Marginal adaptation) [12 months]

      (USPHS) criteria

    Secondary Outcome Measures

    1. Clinical performance (Anatomical form, Secondary caries, marginal discoloration, Postoperative sensitivity, Color match, Retention) [12 months]

      (USPHS) criteria

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion criteria:
    • Patients with High caries risk.

    • Patients with poor oral hygiene.

    • Patients with untreated cervical caries lesion.

    • patient aging ≥18 years.

    • Absence of tooth mobility

    • Absence of abnormal occlusion.

    • Patients with good likelihood of recall availability.

    Exclusion criteria:
    • Patients with cervical caries lesions need crown restoration.

    • Non-vital teeth.

    • Evidence of parafunctional habits.

    • Teeth supporting removable prosthesis.

    • Periapical Abscess or Fistula.

    • Patients with systemic disease.

    • Patients with xerostomia.

    • Participants with a history of allergy to any component of restorations will be used in the study.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    hadeel alsalamony, Principle investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT04716517
    Other Study ID Numbers:
    • 381020
    First Posted:
    Jan 20, 2021
    Last Update Posted:
    Jul 28, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jul 28, 2021